-+ 0.00%
-+ 0.00%
-+ 0.00%

Kestra FY26 net loss widens to $131.61 million; revenue rises 59% to $95.1 million

PUBT·07/14/2026 20:01:31
Listen to the news
Kestra FY26 net loss widens to $131.61 million; revenue rises 59% to $95.1 million
  • Kestra posted fiscal 4Q26 revenue of $28.6 million, up 66% year over year; net loss narrowed to $38.8 million.
  • Gross margin widened 10.5 percentage points to 54.8%.
  • ASSURE system prescriptions rose 63% to 6,357.
  • FY26 revenue climbed 59% to $95.1 million; net loss widened to $131.6 million.
  • Guided FY27 revenue of $137 million, implying 44% growth from FY26.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kestra Medical Technologies Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607141601PRIMZONEFULLFEED9762031) on July 14, 2026, and is solely responsible for the information contained therein.